Tagged Articles

GERD 52 articles

Tips for managing heartburn symptoms this Thanksgiving

The week of Thanksgiving is the 18th Annual GERD Awareness Week. Gastroesophageal reflux disease, or GERD, is very common, affecting millions of Americans. Its most common symptom is heartburn, specifically heartburn that occurs multiple times a week, is severe enough to wake a person from sleep, or occasional heartburn that is associated with difficulty swallowing or has persisted for five or more years. Another common symptom is acid regurgitation. Other less common symptoms include belching, difficulty or pain when swallowing, sudden excess of saliva, dysphagia (the sensation of food sticking in the esophagus), chronic sore throat, laryngitis, inflammation of the gums, ... Read More

Thanksgiving week is also GERD Awareness Week

Gastroesophageal reflux disease, or GERD, is most commonly associated with symptoms of heartburn and acid reflux and it affects millions of Americans. It occurs when the barrier between the stomach and esophagus is compromised and the stomach’s contents flow back into the esophagus. It can cause tissue damage to the lining of the esophagus and can increase risk of a pre-cancerous disease called Barrett’s esophagus. Perhaps appropriately, the week when most Americans are likely to overeat as they celebrate Thanksgiving with a feast of turkey, dressing, cranberry sauce, numerous casseroles and slices of pie, Nov. 19-25, 2017 is GERD Awareness ... Read More

Acid-reducing drugs only treat reflux symptoms

The Cape Gazette features an article by naturopathic doctor Kim Furtado about healing GERD, or gastroesophageal reflux disease, with a different mindset than the traditional pharmaceutical approach. She says that commonly prescribed drugs known as proton pump inhibitors (PPIs), sold under the brand names Prevacid, Nexium, Prilosec, Protonix and Aciphex, treat symptoms instead of the root problem, providing relief but never healing. These drugs often create dependency leading to long-term use, which has been linked to many disturbing side effects such as gastric and colorectal cancer, gastrointestinal bacterial infections, community-acquired pneumonia, nutritional deficiencies, osteoporosis, central nervous system effects including memory ... Read More

Clinical study supports effectiveness of non-drug treatment for infant acid reflux, Safe alternative to PPIs

A new clinical study looks at the effectiveness of the Bare Air-Free feeding system as a non-drug treatment for infant acid reflux by tracking the changes in acid reflux (or GER) symptoms in 122 infants over a two-week period. The infants were divided into a control group with typical GI functioning and a GER group that had clinically significant ratings of GER symptoms based on the Infant- GER Questionnaire (I-GERQ). The researchers found that not only did the Bare Air-Free reduce clinical symptoms in the GER group, 75 percent of the babies in that group no longer met the clinical ... Read More

GERD patients are unhappy with PPI treatment

In a series on on drug development in gastroenterology from members of the American Gastroenterological Association (AGA) Center for Diagnostics and Therapeutics, Applied Clinical Trials features an article called “GERD Treatment: Where We Went Wrong.” In the article Dr. Colin W. Howden addresses the fact that many patients are now dissatisfied with their PPI treatment. Proton pump inhibitors, or PPIs, which in the early nineties had just been approved, had physicians optimistic for the treatment of gastroesophageal reflux disease, or GERD. Previously, GERD was being treated with H2-receptor antagonists, which Dr. Howden reports were sometimes being taken in excessive doses ... Read More

PPI treatment Prevpac linked to serious hypersensitivity reactions

A new hypersensitivity reaction warning has been added to the safety label of the prescription proton pump inhibitor (PPI) Prevpac, a package of medications used to treat stomach ulcers, gastroesophageal reflux disease (GERD), damaged esophaguses, and conditions that cause the stomach to produce too much acid. Prevpac consists of a daily administration card containing two PREVACID (lansoprazole) 30 mg capsules, four amoxicillin 500 mg capsules, and two clarithromycin 500 mg tablets. The drugs treat or prevent infections that are proven or strongly suspected to be caused by bacteria. The new warnings inform health care providers to immediately discontinue use and ... Read More

Study looks at safety of Reglan as treatment for morning sickness

The acid reflux drug metoclopramide may be a safe and effective morning sickness treatment for pregnant women, a new study suggest. Metoclopramide, also known by the brand name Reglan, is used to treat esophageal reflux disease (GERD), nausea, vomiting and diabetic gastroparesis, a condition in which the stomach digests food too slowly. Researchers looked at data from more than 40,000 women who were given metoclopramide while pregnant and found they were no more likely to have a miscarriage or have a baby with birth defects than women who did not take the drug. About half of all pregnant women experience nausea ... Read More

Injectable Reglan, Zofran recalled due to hazardous vial defect

Some injectable medications used to treat severe acid reflux and other gastrointestinal conditions are being recalled because tiny strands of glass were found in some vials. If the glass comes loose and is injected in to patients, it could cause serious and potentially life threatening consequences. The nationwide recall involves one lot of metoclopramide injection and two lots of ondansetron injection. Metocloparmide is known by the brand name Reglan and is used to treat gastric esophageal reflux disease (GERD), and a heartburn condition known as gastroparesis in diabetics. Ondansetron, known by the brand names Zofran and Zuplenz, prevents nausea and vomiting ... Read More

Long-term PPI use linked to low serum magnesium levels

The Food and Drug Administration (FDA) is notifying doctors that long-term use of heartburn medications known as proton pump inhibitors, or PPIs, may cause low serum magnesium levels, a condition known as hypomagnesaemia, which can lead to potentially serious health problems such as muscle spasms, irregular heartbeats, and convulsions. The condition is most often seen in patients who have used PPIs for more than a year. PPIs are used to treat acid reflux, heartburn and other gastrointestinal conditions such as gastroesophageal reflux disease (GERD), stomach and small intestine ulcers, and inflammation of the esophagus. They work by reducing the amount ... Read More

Metozolv label has new tardive dyskinesia warning

The new chewable heartburn medication Metozolv, an orally disintegrating version of Reglan (metoclopramide), has added a warning to its label alerting users of a risk of the serious movement disorder Tardive Dyskinesia with long-term use of the drug. The change to the drug’s safety label was approved by the Food and Drug Administration (FDA) and announced this month. The updated information to the drug’s WARNINGS section reinforces the Boxed Warning that was added to all metoclopramide-containing drugs in June 2009. The new warning states, “Treatment with metoclopramide can cause Tardive Dyskinesia (TD), a potentially irreversible and disfiguring disorder characterized by ... Read More